FDA recall, , Low risk
LifeSouth Community Blood Centers Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were distributed without being labeled as containing red blood cell antibodies.
Recall ended Jul 13, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeSouth Community Blood Centers, Inc. began a recall of Red Blood Cells, Leukocytes Reduced on August 15, 2025, because the units were distributed without being labeled as containing red blood cell antibodies. The FDA added the recall to its Enforcement Report and classified it on July 13, 2026, with the weekly enforcement report dated July 22, 2026. The product was distributed in Florida.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeSouth Community Blood Centers, Inc
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99182
- Recall number
- B-0126-2026
All recalls from LifeSouth Community Blood Centers, Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
